InVivo Therapeutics Holdings Corp. (NVIV) |
|
0.49 -0 (-0.02%)
|
10-15 09:30 |
|
Open: |
0.4901 |
Pre. Close: |
0.4901 |
|
High:
|
0.49 |
Low:
|
0.49 |
|
Volume:
|
2 |
Market Cap:
|
5M |
|
|
|
|
InVivo Therapeutics Holdings Corp is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.501 - 0.504 |
0.504 - 0.506 |
|
Low:
|
0.483 - 0.486 |
0.486 - 0.49 |
|
Close:
|
0.495 - 0.5 |
0.5 - 0.505 |
|
Technical analysis |
as of: 2019-10-14 4:48:07 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 0.71 One year: 0.82 |
| Support: |
Support1: 0.45 Support2: 0.37 |
| Resistance: |
Resistance1: 0.60 Resistance2: 0.70 |
| Pivot: |
0.51  |
| Moving Average: |
MA(5): 0.48 MA(20): 0.52
MA(100): 0.67 MA(250): 1.25 |
| MACD: |
MACD(12,26): -0.03 Signal(9): -0.03 |
| Stochastic oscillator: |
%K(14,3): 23.60 %D(3): 22.05 |
| RSI: |
RSI(14): 43.25 |
| 52-week: |
High: 2.75 Low: 0.45 Change(%): -75.1 |
| Average Vol(K): |
3-Month: 3758 10-Days: 1577 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.NVIV has closed above bottom band by 41.3%. Bollinger Bands are 53.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to NVIV's normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
2019-09-24
The Daily Biotech Pulse: Sandoz Recalls Ulcer Drug, Anchiano Strikes Agreement With ADT Pharma, Proteon Announces Reverse Merger
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Sept. 23.) Applied Therapeutics Inc (NASDAQ: APLT ) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) ( announced a communication from the FDA allowing it to proceed with a reduced sample size in a Phase 3 study of its drug to treat excessive daytime sleepiness) Bioanalytical Systems, Inc. (NASDAQ: BASI ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Celgene Corporation (NASDAQ: CELG ) Cesca Therapeutics Inc (NASDAQ: KOOL ) DURECT Corporation (NASDAQ: DRRX ) Enlivex Therapeutics Ltd (NASDAQ: ENLV ) Sanofi SA (NASDAQ: SNY ) SpringWorks Therapeutics Inc (NASDAQ: SWTX ) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Down In The Dumps (Biotech stocks that hit 52-week lows Sept. 23) Aduro BioTech Inc (NASDAQ: ADRO ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Akcea Therapeutics Inc (NASDAQ: AKCA ) (announced departures of CEO, president and COO, and the appointment of board member Damien McDevitt as interim CEO) BioNano Genomics Inc (NASDAQ: BNGO ) Catalyst Biosciences Inc (NASDAQ: CBIO ) Cellectis SA (NASDAQ: CLLS ) Clovis Oncology Inc (NASDAQ: CLVS ) (announced acquisition of rights to FAP-targeted radiopharmaceuticals from 3B Pharmaceuticals for $12 million) Erytech Pharma SA (NASDAQ: ERYP ) Invivo Therapeutics Holdings Corp (NASDAQ: NVIV ) Kalvista Pharmaceuticals Inc (NASDAQ: KALV ) KITOV PHARMA LT/S ADR (NASDAQ: KTOV ) Mersana Therapeutics Inc (NASDAQ: MRSN ) Neon …
2019-07-25
The Daily Biotech Pulse: Setback For Bristol-Myers Squibb, Gemphire Explodes, Lilly's Nasal Low Blood Sugar Drug
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 24) Acasti Pharma Inc (NASDAQ: ACST ) Cardiovascular Systems Inc (NASDAQ: CSII ) Grifols SA - ADR ADR Class B (NASDAQ: GRFS ) Masimo Corporation (NASDAQ: MASI ) VolitionRX Ltd (NYSE: VNRX ) Edwards Lifesciences Corp (NYSE: EW )(reported a beat-and-raise second quarter) Haemonetics Corporation (NYSE: HAE ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 24) Autolus Therapeutics Ltd – ADR (NASDAQ: AUTL ) Dynavax Technologies Corporation (NASDAQ: DVAX ) Five Prime Therapeutics Inc (NASDAQ: FPRX ) Foamix Pharmaceuticals Ltd (NASDAQ: FOMX ) GENFIT S A/ADR (NASDAQ: GNFT ) ContraVir Pharmaceuticals Inc (NASDAQ: HEPA) Innoviva Inc (NASDAQ: INVA ) Invivo Therapeutics Holdings Corp (NASDAQ: NVIV ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Marinus Pharmaceuticals Inc (NASDAQ: MRNS ) Neovasc Inc (NASDAQ: NVCN ) Organogenesis Holdings Inc (NASDAQ: ORGO ) Pluristem Therapeutics Inc. (NASDAQ: PSTI )(announced 1-for-10 reverse stock split) Regulus Therapeutics Inc (NASDAQ: RGLS )(FDA imposed partial clinical hold on its kidney disease drug) Surface Oncology Inc (NASDAQ: SURF ) Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) Wave Life Sciences Ltd (NASDAQ: WVE ) Stocks In Focus FDA Approves Lilly's Nasally-Administered Low Blood Sugar Drug Eli Lilly And Co (NYSE: LLY ) said the FDA has approved its Baqsimi, the first and only nasally administered glucagon to treat severe hypoglycemia in a single, fixed, 3mg dose.
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
